Articles related to Hematology/Oncology

This study provides concrete data on the proportion of cancer cases attributable to modifiable risk factors, offering a powerful tool for patient education and risk reduction strategies.

The pressure to publish extensively, attend numerous conferences, and navigate academic tribalism is causing young oncologists to reconsider careers in academia, potentially impacting the future of cancer research and treatment.

AL amyloidosis presents a diagnostic challenge due to its varied symptoms, but advancements in therapeutic options, including CyBorD plus daratumumab and emerging antifibril monoclonal antibodies, offer hope for better patient management.

In a recent study, 95% of ITP patients treated with the novel anti-CD38 monoclonal antibody, CM313, achieved two consecutive platelet counts of at least 50×10^9 per liter within just eight weeks, highlighting the therapy’s efficacy and rapid action.

AI chatbots like ChatGPT-4 and Claude AI have demonstrated superior performance to oncologists in delivering accurate, empathetic, and readable responses to patient inquiries about cancer, suggesting a promising adjunct to clinical practice.

Tempus AI, leveraging one of the world’s largest clinical and molecular oncology data libraries, files for an IPO, aiming to raise substantial funds to support its mission of advancing AI-powered precision medicine.